Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4 Open-market sale Chief Operations Officer sold 3,886 shares at $20.39 ($79,236)
  2. 4 Open-market sale Chief Operations Officer sold 7,000 shares at $18.84 ($131,880)
  3. 4 Open-market sale Chief Operations Officer sold 7,000 shares at an average $23.11 ($161,735)
  4. 4/A Derivatives Options or other derivatives
  5. 4 Open-market sale Chief Financial Officer sold 1,469 shares at $19.77 ($29,048)
  6. 4 Open-market sale Chief Operations Officer sold 1,648 shares at $19.77 ($32,588)
  7. 4 Open-market sale President and CEO sold 4,716 shares at $19.77 ($93,254)
  8. 4 Open-market sale Chief Operations Officer sold 7,500 shares at an average $18.49 ($138,688)
  9. 4 Open-market sale President and CEO sold 4,807 shares at $12.09 ($58,117)
  10. 4 Open-market sale Chief Financial Officer sold 1,496 shares at $12.09 ($18,087)
  11. 4 Open-market sale Chief Operations Officer sold 1,678 shares at $12.09 ($20,287)
  12. 4 Open-market sale President and CEO sold 12,135 shares at $12.92 ($156,784)
  13. 4 Grant or award Director acquired 8,000 shares (grant or award)
  14. 4 Grant or award Director acquired 8,000 shares (grant or award)
  15. 4 Grant or award Director acquired 8,000 shares (grant or award)
  16. 4 Grant or award Director acquired 8,000 shares (grant or award)
  17. 4 Grant or award Director acquired 8,000 shares (grant or award)
  18. 4 Grant or award Director acquired 8,000 shares (grant or award)
  19. 4 Open-market sale Chief Financial Officer sold 3,924 shares at $10.18 ($39,946)
  20. 4 Open-market sale Chief Operations Officer sold 1,603 shares at $11.22 ($17,986)

Page 11 of 33 · 645 filings